id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-D-0094-0032,FDA,FDA-2002-D-0094,"Guidance for the Public, Advisory Committee Members, and Staff;  Advisory Committee Members' Financial Interest Information and Waivers",Other,Guidance,2012-03-09T05:00:00Z,2012,3,2012-03-09T05:00:00Z,,2024-11-07T22:28:07Z,,1,0,0900006480fd2db6
FDA-2002-D-0094-0031,FDA,FDA-2002-D-0094,"Guidance for the Public, Advisory Committee Members, and Staff;  Advisory Committee Members' Financial Interest Information and Waivers: Availability",Notice,Notice of Availability,2012-03-09T05:00:00Z,2012,3,2012-03-09T05:00:00Z,,2012-03-09T15:34:01Z,2012-05776,0,0,0900006480fd2859